|
Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
| 178.29 USD | -8.57% |
|
-.--% | +1.59% |
| Market Cap | 245B 212B 198B 182B 344B 23,350B 347B 2,329B 912B 11,643B 920B 899B 38,622B | P/E 2026 * |
20.2x | P/E 2027 * | 17.6x |
|---|---|---|---|---|---|
| Enterprise Value | 265B 230B 214B 197B 372B 25,265B 376B 2,520B 986B 12,598B 995B 973B 41,791B | EV / Sales 2026 * |
4.19x | EV / Sales 2027 * | 3.85x |
| Free-Float |
96.63% | Yield 2026 * |
2.11% | Yield 2027 * | 2.23% |
Last Transcript: AstraZeneca PLC
| 1 day | -8.57% |
| Manager | Title | Age | Since |
|---|---|---|---|
Pascal Soriot
CEO | Chief Executive Officer | 66 | 01/10/2012 |
Aradhana Sarin
DFI | Director of Finance/CFO | 52 | 01/08/2021 |
Jeffrey Pott
CMP | Compliance Officer | - | 01/01/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 70 | 06/04/1999 | |
Pascal Soriot
BRD | Director/Board Member | 66 | 01/10/2012 |
Philip Broadley
BRD | Director/Board Member | 65 | 27/04/2017 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -8.57% | -.--% | - | - | 239B | |
| -0.51% | -6.83% | +46.35% | +148.39% | 1T | |
| +0.20% | -4.14% | +52.35% | +49.40% | 613B | |
| -0.53% | -5.10% | +24.88% | +63.57% | 433B | |
| +0.48% | -0.67% | +39.13% | +34.00% | 350B | |
| +0.08% | -3.05% | +32.29% | +39.91% | 292B | |
| +1.75% | -5.79% | -0.39% | -42.69% | 206B | |
| +2.94% | +3.66% | +31.37% | +69.06% | 204B | |
| +3.13% | +3.62% | +19.50% | +79.07% | 163B | |
| +1.52% | +3.00% | +8.17% | -27.40% | 143B | |
| Average | -0.33% | -2.47% | +28.18% | +45.92% | 378.19B | |
| Weighted average by Cap. | -0.01% | -3.63% | +36.14% | +71.70% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 63.27B 54.86B 51.19B 47.03B 88.95B 6,034B 89.77B 602B 236B 3,008B 238B 232B 9,980B | 66.84B 57.96B 54.09B 49.69B 93.98B 6,374B 94.85B 636B 249B 3,178B 251B 245B 10,544B |
| Net income | 12.09B 10.48B 9.78B 8.98B 16.99B 1,153B 17.15B 115B 45B 575B 45.39B 44.38B 1,906B | 13.71B 11.89B 11.09B 10.19B 19.28B 1,308B 19.46B 130B 51.05B 652B 51.49B 50.35B 2,163B |
| Net Debt | 20.09B 17.42B 16.25B 14.93B 28.24B 1,916B 28.5B 191B 74.79B 955B 75.44B 73.77B 3,169B | 12.3B 10.66B 9.95B 9.14B 17.29B 1,173B 17.45B 117B 45.8B 585B 46.19B 45.17B 1,940B |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- AZN Stock
- AZN Stock
Select your edition
All financial news and data tailored to specific country editions
